Blog

COVID-19 by the Numbers: What You Need to Know About The Coronavirus in the U.S. When the coronavirus first broke out, little was known about it, thus leaving countries struggling to respond to the health and economic crisis that it caused. A year in and after much effort from the scientific community to understand the …

In a press release dated October 11, 2021, American pharmaceutical company Merck has announced it has formally submitted an Emergency Use Authorization (EUA) application to the US Food and Drug Administration (FDA) for molnupiravir, which is being touted as a possible Covid game changer. Apparently, the new drug will be the first oral antiviral treatment …

Amid the reopening of schools in New York City and the spread of the highly transmissible Delta variant, parents, school officials, government authorities, and health experts are doing their best to deal with the ongoing pandemic while allowing learners to move forward in their academic endeavors.     Here are some news bits we’ve gathered about the …

  Hindsight can be highly illuminating – and a look back on the early days of the global pandemic is a fascinating exercise, considering everything that we now know.    Here we revisit the government’s response to the Covid-19 in NYC crisis – a cautionary tale if ever there was one:   The First Case …